Bright 647 Anti-Human HLA-DR Antibody[Tü36]
![Staining of normal human peripheral blood cells with FITC Anti-Human CD19 Antibody and 647 Anti-Human HLA-DR Anyibody[Tü36] (left) or 647 Mouse IgG2b, κ Isotype Control (right). Cells in the lymphocytes gate were used for analysis.](/storage/products/wp-images/2026/06/product_729_img_1.png)
Staining of normal human peripheral blood cells with FITC Anti-Human CD19 Antibody and 647 Anti-Human HLA-DR Anyibody[Tü36] (left) or 647 Mouse IgG2b, κ Isotype Control (right). Cells in the lymphocytes gate were used for analysis.
| Catalog Number: | MAB00994 |
| Conjugate: | Bright 647 |
| Size: | 100 tests |
| Host: | Mouse |
| Isotype: | Mouse IgG2b, κ |
| Clone: | Tü36 |
| Reactivity: | Human |
| Applications: | FCM Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. |
| Form: | Liquid |
| Synonyms: | MHC class II;Major Histocompatibility complex II;human leukocyte antigen;HLA |
HLA-DR is a heterodimeric cell surface glycoprotein comprised of an α (heavy) chain and a β (light) chain. They are expressed on B cells, activated T cells, monocytes/macrophages, dendritic cells, and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. Variations in the HLA gene expression are crucial to graft survival.
Applications
FCM Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.